TWO CASES OF MPO-ANCA-POSITIVE EGPA WITH CHRONIC RHINOSINUSITIS SHOWING DIFFERENT RESPONSES TO MEPOLIZUMAB

DOI PubMed
  • Kamimura Seiichiro
    Department of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School
  • Morozumi Ryota
    Department of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School
  • Ishitani Keisuke
    Department of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School
  • Kitamura Yoshiaki
    Department of Otolaryngology, Institute of Biomedical Sciences, Tokushima University Graduate School

Bibliographic Information

Other Title
  • MPO-ANCA陽性のEGPAに伴う鼻副鼻腔炎に対するメポリズマブの効果が異なった2症例
Published
2025-10-10
Resource Type
journal article
DOI
  • 10.15036/arerugi.74.277
Publisher
Japanese Society of Allergology

Search this article

Description

<p>Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis associated with chronic rhinosinusitis (CRS) and bronchial asthma. Mepolizumab, an anti-IL-5 monoclonal antibody, has been used in the treatment of EGPA. We report two cases of MPO-ANCA-positive EGPA with CRS that exhibited differing responses to mepolizumab. In Case 1, nasal symptoms persisted despite mepolizumab treatment, and CRS recurred early after endoscopic sinus surgery (ESS). In contrast, Case 2 developed EGPA following dupilumab administration, but nasal symptoms improved with mepolizumab and remained well controlled. These cases suggest that the efficacy of mepolizumab for CRS in ANCA-positive EGPA varies among patients. Even in cases that respond well to treatment, recurrence may still occur, underscoring the importance of continuous follow-up in close collaboration with internal medicine specialists.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top